| > perhaps more people would die from the effects of new drugs I'd argue this is almost certainly a given. But the problem is not those who die now - but those who are taken ill much later down the line. Ten years or whatever. > but you could choose to only use drugs that have been stable and well studied while those who have nothing left to lose could use medicine directly off the chemists work bench. I entirely agree with the sentiment there (it would be great to see the wider liberalisation and faster iteration of new drug trials for example). but (and I feel this is a big caveat) how do people decide which drug is stable and well studied. It is not necessarily sufficient to trust the pamphlet or advertising the company gives you. I don't know. Maybe it is cynicism but I suspect that if drug research were deregulated the standard of drugs produced would decline rapidly. And finally; I am not so sure drugs research would explode with innovation. We would get drugs to market faster, sure, but there is a standard of entry into drug research that still requires funding, education and resources. |
It probably would. But that is irrelevant - the relevant question is, "would consumers benefit?"
A hypothetical - imagine that government regulations forbid the sales of laptops weighing more than 4lb, having less than 8gb ram and a 500gb HD (roughly a $5,000 laptop). Eliminating this regulation would almost certainly result in lower quality laptops (read: bigger, less ram) being sold.
Would that be a bad thing?